Lifeway Foods CEO on Hostile Takeover Bid by Danone

Hostile Takeover Defense

• 🛡️ Lifeway Foods is actively defending against what CEO Julie Smolyansky calls a hostile takeover attempt by Danone, a major shareholder for over 25 years.
• ⚖️ The company is in court, arguing that Danone's offer undervalues Lifeway and that the disputed contract is invalid and against Illinois state law.
• 🏛️ Smolyansky likens the situation to a David and Goliath story, with Lifeway fighting against the world's largest B Corp behaving like an activist investor.

Danone's Response and Lifeway's Counterarguments

• ❌ Danone claims there is no hostile bid, stating Lifeway's board rejected their attractive $27-per-share acquisition proposal.
• 📜 Lifeway asserts the shareholder agreement Danone is defending is illegal and improper, harming Lifeway and the public, while benefiting only Danone.
• 📈 Danone's alleged plan is to wipe out Lifeway's brand and take over the US kefir market, a move Smolyansky calls a standard operating procedure for them, citing past takeovers.

The Value of Kefir and Lifeway's Growth

• 🚀 Lifeway Foods, a $350 million market cap company, is a leader in the kefir and farm cheese markets, with 22 consecutive quarters of growth under Smolyansky's leadership.
• 🔬 Kefir is highlighted as a 2,000-year-old stable product with significant scientific backing, including research linking probiotic fermented dairy to reduced colon cancer risk and benefits for the mind-gut axis.
• 📈 The company has seen 1,200% growth over five years, with significant increases in EBITDA and gross profit, and is investing in capacity for continued expansion.

Farmer's Cheese and Market Trends

• 🌟 Farmer's cheese is identified as a current hot product, benefiting from the trend in demand for soft, unripened cheeses like cottage cheese.
• 🛒 Lifeway is scaling its farmer's cheese product, securing distribution in 1,400 Albertson stores and commitments for 2,000 more points of distribution.
• 🥛 Fermented dairy like kefir offers unique benefits beyond regular milk, with peptides released during fermentation that create a healthy gut microbiome, appealing to consumers increasingly aware of the importance of food as medicine.

Financial Performance and Future Outlook

• 📊 Despite a recent share price dip, Lifeway's five-year trajectory shows 872% growth, with strong financial metrics including no debt and cash in the bank.
• ⏳ Lifeway has navigated inflationary pressures and market challenges for nearly 40 years, demonstrating resilience and the ability to manage price adjustments if necessary.
• 🌍 The company's goal is to democratize kefir, making it accessible and available globally, leveraging its position as the OG of probiotics and a brand that meets the moment.